RSS

Sanofi

The US Food and Drug Administration (FDA) has approved Sanofi’s short-acting insulin (Admelog — insulin lispro injection) as a ‘follow on’ product to treat diabetes. more

12 Dec 2017 12:19 News

Sanofi is requesting that health authorities update information on its dengue vaccine Dengvaxia, as a result of a new analysis of long-term clinical trial data, which found differences in vaccine performance based on prior dengue infection. more

30 Nov 2017 14:53 News

Lead Pharma has achieved a third milestone under its research collaboration with Sanofi, which has triggered an undisclosed milestone payment. more

22 Nov 2017 12:34 News

Sanofi and Principia Biopharma have entered into an agreement to develop a clinical-stage oral drug candidate as a potential therapy for multiple sclerosis (MS) and other central nervous system (CNS) diseases. more

10 Nov 2017 09:00 News

Sanofi and Regeneron Pharmaceuticals have revealed positive results from a Phase II investigational study of dupilumab, for the treatment of adults with moderate-to-severe eosinophilic oesophagitis. more

17 Oct 2017 12:28 News

Global healthcare company Sanofi has announced it is investing €170 million to expand its vaccine manufacturing site in Val de Reuil, France. more

12 Oct 2017 12:46 News

The European Commission (EC) has granted marketing authorisation to Sanofi and Regeneron Pharmaceuticals for dupilumab (Dupixent) for the treatment of adults with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy. more

28 Sep 2017 12:00 News

Sanofi and Regeneron Pharmaceuticals have revealed that the US Food and Drug Administration (FDA) has granted breakthrough therapy designation status to cemiplimab (REGN2810), an investigational human, monoclonal antibody. more

11 Sep 2017 14:30 News

A research collaboration between Axxam and Sanofi has been announced, which will be aimed at further optimising several small molecules targeted against a range of diseases of the central nervous system (CNS). more

5 Sep 2017 12:00 News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

1 Sep 2017 13:58 News

Sanofi has announced the completion of its acquisition of a privately-held US vaccines biotech company, Protein Sciences, following Federal Trade Commission approval. more

29 Aug 2017 15:37 News

Sanofi and Regeneron Pharmaceuticals have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion for marketing authorization of Dupixent (dupilumab). more

24 Jul 2017 10:00 News

Biopharmaceutical company, Ablynx, and Sanofi have entered into a strategic collaboration for the development of Nanobody based therapeutics for the treatment of immune-mediated inflammatory diseases. more

20 Jul 2017 12:22 News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

14 Jul 2017 15:51 News

Sanofi has revealed it will acquire Protein Sciences, a privately held vaccines biotechnology company based in Meriden, Connecticut, which will add the only recombinant-based flu vaccine approved by the US Food and Drug Administration (FDA) to its po more

11 Jul 2017 12:19 News

Sanofi and Regeneron Pharmaceuticals have announced that the European Commission (EC) has granted marketing authorisation of Kevzara in combination with methotrexate for the treatment of moderately to severely active rheumatoid arthritis in adults more

27 Jun 2017 11:45 News

Global biopharmaceutical services organisation, Parexel, and global life sciences company, Sanofi, are collaborating on a pilot study to advance the use of wearable devices in the collection of data and management of clinical trials. more

19 Jun 2017 12:04 News

Sanofi and Regeneron Pharmaceuticals have announced positive results from two Phase IIIb/IV ODYSSEY-DM trials evaluating Praluent (alirocumab) in patients with diabetes and hypercholesterolemia. more

12 Jun 2017 10:39 News

Jean-Marc Bobée, former director, industrial anti-counterfeiting strategy at Sanofi, outlines global and local traceability concepts and their individual ‘security to cost’ ratios, highlighting the need for a standardised global serialisation more

26 May 2017 15:44 Opinion

Sanofi and Regeneron Pharmaceuticals have announced the FDA’s approval of Kevzara (sarilumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) more

25 May 2017 11:44 News